News Search Results
Jan 09, 2026, 14:07 ET Rain huy động được 250 triệu đô la trong vòng gọi vốn Series C để mở rộng cơ sở hạ tầng thanh toán bằng Stablecoin cho các doanh nghiệp toàn cầu
Rain, cơ sở hạ tầng cấp doanh nghiệp dành cho các khoản thanh toán bằng stablecoin, hôm nay đã công bố vòng gọi vốn Series C trị giá 250 triệu đô la do ICONIQ dẫn dắt, với sự tham gia của Sapphire Ventures, Dragonfly, Bessemer Venture Partners, Galaxy Ventures, FirstMark,
More news about: Rain
Jan 09, 2026, 12:40 ET M&G champions UK innovation in drug discovery by leading US$50 million funding round for biotech company bit.bio
LONDON, Jan. 9, 2026 /PRNewswire/ -- M&G Investments (M&G) today announces that it has led a US$50 million Series C funding round for
More news about: bit.bio; M&G Investments
Jan 09, 2026, 12:31 ET M&G champions UK innovation in drug discovery by leading US$50 million funding round for biotech company bit.bio
LONDON, Jan. 9, 2026 /PRNewswire/ -- M&G Investments (M&G) today announces that it has led a US$50 million Series C funding round for
More news about: bit.bio; M&G Investments
Jan 09, 2026, 06:30 ET Rain Raises $250M Series C to Scale Stablecoin-Powered Payments Infrastructure for Global Enterprises
Rain, the enterprise-grade infrastructure for stablecoin-powered payments, today announced a $250 million Series C funding round led by ICONIQ, with participation from Sapphire Ventures, Dragonfly, Bessemer Venture Partners, Galaxy Ventures, FirstMark, Lightspeed,
More news about: Rain
Jan 09, 2026, 06:30 ET Rain Raises $250M Series C to Scale Stablecoin-Powered Payments Infrastructure for Global Enterprises
Rain, the enterprise-grade infrastructure for stablecoin-powered payments, today announced a $250 million Series C funding round led by ICONIQ, with participation from Sapphire Ventures, Dragonfly, Bessemer Venture Partners, Galaxy Ventures, FirstMark, Lightspeed,
More news about: Rain
Jan 08, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
and this $3.55 per share price was significantly less than the $10.50 per share offering price in the Company's Series C stock offering in 2022; and (5) as a result, investors in the Series C stock offering would likely lose their investment.Pomerantz LLP, with offices in New York, Chicago, Los
More news about: Pomerantz LLP
Jan 08, 2026, 07:45 ET Pomelo Care Raises $92 Million Series C, Reaches $1.7 Billion Valuation, to Expand Its Proven Model Beyond Maternity & Set a New National Standard for Women's and Children's Healthcare
Pomelo Care, the national leader in evidence-based healthcare for women and children, announced it has raised $92 million in Series C funding led by
More news about: Pomelo Care
Jan 07, 2026, 10:00 ET Neural Concept Introduces a Physics- and Geometry-Aware AI Design Copilot, Extending Its Established Engineering AI Platform
intent. Neural Concept's launch of its AI Design Copilot builds on the company's rapid market growth, strengthened last month by its $100 million Series C round, led by Goldman Sachs. Today's engineers face unprecedented complexity as products now span multiple physics and domains, and the number
More news about: Neural Concept
Jan 07, 2026, 09:00 ET Marshall Mohr Joins Capstan Medical Board of Directors
strengthens our board as we move into our next phase of growth in 2026 and beyond."In late 2024, the company announced an oversubscribed $110 million Series C financing, followed in early 2025 by the successful completion of pioneering first-in-human robotic-assisted transcatheter mitral valve replacement
More news about: Capstan
Jan 07, 2026, 08:45 ET Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds
shares of Common Stock (or, in certain circumstances, Pre-Funded Warrants), and (iv) Series C warrants to purchase 26,926,675 shares of Common Stock (or, in certain circumstances, Pre-Funded Warrants) (the "Series C Warrants" and, together with the Series A Warrants and the Series B Warrants, the "Warrants").
More news about: Curis, Inc.
Jan 07, 2026, 06:00 ET Hyperscale Data Announces Estimated Total Assets and Net Assets per Share of $1.14 and $0.50, Respectively, as of December 31, 2025
of a newly designated Series F Exchangeable Preferred Stock (the "Series F Preferred Stock") to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of
More news about: Hyperscale Data Inc.
Jan 06, 2026, 06:00 ET Hyperscale Data Bitcoin Treasury at 532.6978 Bitcoin and Held Approximately $43.1 Million of Cash as of January 2, 2026
of a newly designated Series F Exchangeable Preferred Stock (the "Series F Preferred Stock") to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of
More news about: Hyperscale Data Inc.
Jan 01, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in NowRx, Inc. of Class Action Lawsuit and Upcoming Deadlines
and this $3.55 per share price was significantly less than the $10.50 per share offering price in the Company's Series C stock offering in 2022; and (5) as a result, investors in the Series C stock offering would likely lose their investment.Pomerantz LLP, with offices in New York, Chicago, Los
More news about: Pomerantz LLP
Dec 30, 2025, 20:14 ET Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange
important institutional investors. Qiming Venture Partners led the Company's Series B financing round in 2019 and continued its support in subsequent Series C and D rounds, with an about 7 percent stake in Insilico Medicine before its IPO.Founded in 2014, Insilico Medicine employs a business model
More news about: Qiming Venture Partners
Dec 30, 2025, 19:50 ET Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange
important institutional investors. Qiming Venture Partners led the Company's Series B financing round in 2019 and continued its support in subsequent Series C and D rounds, with an about 7 percent stake in Insilico Medicine before its IPO.Founded in 2014, Insilico Medicine employs a business model
More news about: Qiming Venture Partners
Dec 30, 2025, 06:00 ET Hyperscale Data Bitcoin Treasury at 519.8687 Bitcoin and Held Approximately $47 Million of Cash as of December 26, 2025
of a newly designated Series F Exchangeable Preferred Stock (the "Series F Preferred Stock") to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of
More news about: Hyperscale Data Inc.
Dec 29, 2025, 06:00 ET Hyperscale Data Establishes 2026 Disclosure Schedule for Bitcoin Treasury, Michigan AI Data Center Progress and Monthly Estimated Asset Updates
of a newly designated Series F Exchangeable Preferred Stock (the "Series F Preferred Stock") to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of
More news about: Hyperscale Data Inc.
Dec 23, 2025, 08:33 ET Shift5 Named North American Technology Innovation Leader in Onboard OT Platforms
commercial markets. Over the past year, the company increased headcount by nearly 40%, expanded vehicle deployments by more than 100%, and secured a $75M Series C funding round led by Hedosophia, bringing total funding to $185M."By combining technological breakthroughs, proven deployments, and a clear
More news about: Shift5
Dec 23, 2025, 06:00 ET Hyperscale Data Bitcoin Treasury at 514.9655 Bitcoin and Exceeds 100% of Market Capitalization
of a newly designated Series F Exchangeable Preferred Stock (the "Series F Preferred Stock") to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of
More news about: Hyperscale Data Inc.
Dec 19, 2025, 16:30 ET Hyperscale Data Announces "At-the-Market" Offering of Common Stock
of a newly designated Series F Exchangeable Preferred Stock (the "Series F Preferred Stock") to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of
More news about: Hyperscale Data Inc.
Dec 19, 2025, 16:10 ET cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance
NYSE American Company Guide.On December 18, 2025 cbdMD closed a $2.25 million Series C Convertible Preferred equity financing, generating $2.2 million in net proceeds from the sale of 1,000,000 shares of Series C Convertible Preferred Stock which have rights and preferences substantially the same
More news about: cbdMD, Inc.
Dec 19, 2025, 15:01 ET cbdMD, Inc. Announces Closing of $2.25 Million Series C Preferred Stock Private Placement
shares of Series C Convertible Preferred Stock in consideration of gross proceeds to the Company of $2.25 million. The Company intends to use the net proceeds of approximately $2.1 million for working capital general corporate purposes and support ongoing strategic initiatives. The Series C shares have
More news about: cbdMD, Inc.
Dec 18, 2025, 11:00 ET Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering
a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster
More news about: Neural Concept
Dec 18, 2025, 10:00 ET Nirvana Raises $100 Million Series D to Further Redefine Trillion-Dollar Industry
General Catalyst also doubling down significantly. These top firms reconfirm their conviction in Nirvana following closely on the company's Q1 2025 Series C. In that short time, Nirvana has nearly doubled its valuation, bringing it to a valuation of $1.5 billion. The new capital will accelerate Nirvana's
More news about: Nirvana Insurance
Dec 18, 2025, 08:55 ET Six months an AI unicorn, Parloa surpasses $50M revenue mark
expanded its presence in the North American market by adding staff and relocating its New York HQ to midtown Manhattan, supported by $120 million in Series C funding in May. Parloa is also attracting top-level talent, bringing aboard
More news about: Parloa